Is Tilray the Best Value Play in the $7.4 Billion Cannabis Beverage Market?

Source Motley_fool

Key Points

  • Tilray Brands, a leader in the cannabis industry, has a significant footprint in the beverage market.

  • That could allow the pot grower to cash in on the vast and growing market for cannabis-infused drinks.

  • However, there are significant risks to consider.

  • 10 stocks we like better than Tilray Brands ›

Although cannabis stocks have not performed well over the past five years, there is still some hope left for the industry. According to some projections, the market will continue to expand in the coming years, especially in North America. And it isn't just the demand for dried cannabis flower that will grow. For instance, the market for cannabis-infused beverages might be worth about $7.4 billion this year and could grow to $242.68 billion by 2034, representing a compound annual growth rate of 54.62%.

Tilray Brands (NASDAQ: TLRY) has been a leader in the cannabis market for a while, and it remains so. Is this pot grower the best value stock to buy to capitalize on this expanding opportunity?

Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue »

Tilray logo.

Image source: The Motley Fool.

Why Tilray Brands might be a great pick

Tilray has one of the leading market shares in Canada, where recreational use of marijuana -- including cannabis infused drinks -- are legal. The company expanded its business significantly and now has a large beverage segment, which typically accounts for between 20% and 30% of its quarterly revenue. It isn't just in Canada either. Tilray established itself as a leading craft brewer (specifically, the fourth-largest) in the U.S. market through acquisitions.

That means the company has a network of brands and an established commercial footprint that put it in a strong position to profit from the growing demand for cannabis-infused beverages. True, there are some potential roadblocks. Most notably, marijuana remains illegal at the federal level in the U.S. However, if that were to change in the next eight years, Tilray could be one of the major beneficiaries. Meanwhile, the company's shares are trading at just under $6 apiece. And the company's forward price-to-sales of 0.7 (anything under 2 is usually considered "good") suggests it might be deeply undervalued.

Reasons to be skeptical

Tilray's shares look cheap for a reason: The company's financial results in recent years have been terrible. It has posted inconsistent revenue growth and consistent net losses.

TLRY Revenue (Quarterly) Chart

TLRY Revenue (Quarterly) data by YCharts

It isn't all Tilray's fault. The cannabis market has faced regulatory challenges along with stiff competition that has led to oversupply issues. Even if it isn't Tilray's fault, the fact is that the company's results inspire little confidence. Can the pot grower bounce back? Consider the possibility that cannabis will become legal at the federal level in the U.S. Besides the fact that no one can predict that for sure, it isn't even obvious that it would solve Tilray's problems. After all, the company hasn't performed well despite pot being legal in Canada.

True, the U.S. would present a much larger opportunity than the Canadian market. But the reality on the ground is that legalization would open new avenues for growth, along with new problems. For example, Tilray Brands might have a lead on its peers in the beverage category. However, it wouldn't be that difficult for beverage giants to enter the market for cannabis-infused drinks if marijuana becomes legal at the federal level.

Dealing with competition from cash-rich corporations with well-known brands and deep experience in highly regulated consumer goods niches might not go too well for Tilray. The company might emerge victorious regardless, perhaps by partnering with such a beverage maker. But it's hard to predict that.

Is Tilray Stock a buy?

Tilray faces a challenging, highly competitive market with significant regulatory scrutiny. Further, the industry's prospects remain uncertain. There has been some regulatory progress in the U.S. over the past year -- authorities in the country have officially made marijuana a Schedule III substance, which changes things for the better for corporations in the sector -- but there remain plenty of risks.

Finally, even if Tilray's best-case scenario unfolds and marijuana becomes legal at the federal level in the U.S., the company might still fail to turn things around. In short, Tilray isn't a stock worth considering right now, for value investors and others. It's best to look elsewhere.

Should you buy stock in Tilray Brands right now?

Before you buy stock in Tilray Brands, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Tilray Brands wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $473,985!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,204,650!*

Now, it’s worth noting Stock Advisor’s total average return is 950% — a market-crushing outperformance compared to 203% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of May 6, 2026.

Prosper Junior Bakiny has no position in any of the stocks mentioned. The Motley Fool recommends Tilray Brands. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Here’s Why The BNB Price Could Rally To $12,000 Before EthereumThe BNB price is sitting below the spotlight that has surrounded Bitcoin, Ethereum, and Solana in recent months, but a new technical outlook suggests that this quiet phase may be exactly where the
Author  NewsBTC
21 hours ago
The BNB price is sitting below the spotlight that has surrounded Bitcoin, Ethereum, and Solana in recent months, but a new technical outlook suggests that this quiet phase may be exactly where the
placeholder
Solana Market Structure Warns Of More Downside Despite Oversold ConditionsSolana’s price action continues to flash caution signals, even as momentum indicators suggest oversold conditions. The broader market structure remains tilted to the downside, with bearish waves
Author  NewsBTC
21 hours ago
Solana’s price action continues to flash caution signals, even as momentum indicators suggest oversold conditions. The broader market structure remains tilted to the downside, with bearish waves
placeholder
Ethereum Withdrawals From Exchanges Just Hit An 8-Month Low: Find Out What Investors Are Waiting ForEthereum is holding above $2,300 as the market builds toward what feels like a decisive move in either direction. The price is constructive but unresolved, and an Arab Chain report has just surfaced
Author  NewsBTC
21 hours ago
Ethereum is holding above $2,300 as the market builds toward what feels like a decisive move in either direction. The price is constructive but unresolved, and an Arab Chain report has just surfaced
placeholder
Dogecoin’s XRP Fractal Just Put A Date On The Next ATH Run: AnalystDogecoin may not be finished with its multi-year compression phase if a new XRP fractal chart from analyst Charting Guy continues to track. The setup suggests DOGE’s next decisive run toward a
Author  NewsBTC
21 hours ago
Dogecoin may not be finished with its multi-year compression phase if a new XRP fractal chart from analyst Charting Guy continues to track. The setup suggests DOGE’s next decisive run toward a
placeholder
AMD rose about 5% after beating first-quarter revenue and adjusted earnings estimatesAdvanced Micro Devices (AMD) rose about 5% in late trading Tuesday after the chip company beat Wall Street’s first-quarter targets and gave a stronger sales forecast for the next quarter. AMD reported $10.25 billion in quarterly revenue, above the $9.89 billion expected by LSEG. Adjusted earnings came in at $1.37 per share, beating the $1.29...
Author  Cryptopolitan
21 hours ago
Advanced Micro Devices (AMD) rose about 5% in late trading Tuesday after the chip company beat Wall Street’s first-quarter targets and gave a stronger sales forecast for the next quarter. AMD reported $10.25 billion in quarterly revenue, above the $9.89 billion expected by LSEG. Adjusted earnings came in at $1.37 per share, beating the $1.29...
goTop
quote